These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8906811)

  • 1. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation.
    Pinchuk LM; Klaus SJ; Magaletti DM; Pinchuk GV; Norsen JP; Clark EA
    J Immunol; 1996 Nov; 157(10):4363-70. PubMed ID: 8906811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.
    Peng X; Remacle JE; Kasran A; Huylebroeck D; Ceuppens JL
    J Immunol; 1998 Feb; 160(3):1166-72. PubMed ID: 9570530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.
    Aicher A; Shu GL; Magaletti D; Mulvania T; Pezzutto A; Craxton A; Clark EA
    J Immunol; 1999 Dec; 163(11):5786-95. PubMed ID: 10570261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligand is expressed and functional on activated neonatal T cells.
    Splawski JB; Nishioka J; Nishioka Y; Lipsky PE
    J Immunol; 1996 Jan; 156(1):119-27. PubMed ID: 8598451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms.
    McDyer JF; Dybul M; Goletz TJ; Kinter AL; Thomas EK; Berzofsky JA; Fauci AS; Seder RA
    J Immunol; 1999 Mar; 162(6):3711-7. PubMed ID: 10092834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
    Tada Y; O-Wang J; Yu L; Shimozato O; Wang YQ; Takiguchi Y; Tatsumi K; Kuriyama T; Takenaga K; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligation of CD40 influences the function of human Ig-secreting B cell hybridomas both positively and negatively.
    Bergman MC; Attrep JF; Grammer AC; Lipsky PE
    J Immunol; 1996 May; 156(9):3118-32. PubMed ID: 8617932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD40 ligand expressed by human B cells costimulates B cell responses.
    Grammer AC; Bergman MC; Miura Y; Fujita K; Davis LS; Lipsky PE
    J Immunol; 1995 May; 154(10):4996-5010. PubMed ID: 7537298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
    Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
    J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 ligand exerts differential effects on the expression of I gamma transcripts in subclones of an IgM+ human B cell lymphoma line.
    Ford GS; Yin CH; Barnhart B; Sztam K; Covey LR
    J Immunol; 1998 Jan; 160(2):595-605. PubMed ID: 9551893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
    Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
    J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.
    Altenburg A; Baldus SE; Smola H; Pfister H; Hess S
    J Immunol; 1999 Apr; 162(7):4140-7. PubMed ID: 10201939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
    Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
    J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of cytokine genes and activation of mitogen-activated protein kinase family by soluble CD40 ligand and TNF in a human follicular dendritic cell line.
    Park SM; Kim HS; Choe J; Lee TH
    J Immunol; 1999 Jul; 163(2):631-8. PubMed ID: 10395651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
    Daniel PT; Oettinger U; Mapara MY; Bommert K; Bargou R; Dörken B
    Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.